SCoV-2 Ag Detect™ Rapid Self-Test, Now Available!
Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK® Assay at Chembio Diagnostics Malaysia Facility
Launching Status™ COVID-19/Flu 15 Minute Visual Read Rapid Test in the USA
Launching DPP® SARS-CoV-2 Antigen System in Brazil
Introducing DPP HIV-Syphilis: The First & Only FDA Approved HIV-Syphilis Rapid Test
We enable longer and healthier living through detection and monitoring of infectious diseases at the point of care.
Our mission is to be a leader in the development, manufacturing and commercialization of diagnostic solutions. We are dedicated to delivering exceptional point-of-care products that are easy to use, fast and accurate.
Our Core Values: “RAPID”
Chembio is a leading point of care diagnostics company focused on detecting and diagnosing infectious diseases.
Our patented DPP® technology platform uses a small drop of blood from the fingertip and provides high-quality, cost-effective results in 15-20 minutes. Our products are sold globally, directly and through distributors, to hospitals, clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.